On Thursday, the Food and Drug Administration's committee on compounded drugs voted to add peptides to the permitted list of substances that compounding pharmacies are allowed to manufacture.
The committee's decision broke with agency scientists, who had raised concerns regarding the lack of demonstrated benefits associated with the peptides.
In other pharmaceutical developments, Merck recently secured a license for an HIV pill.
In-depth summary · AI, neutral